Neurology · Headache Disorders
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
The classic patient profile is an obese woman of childbearing age presenting with headaches and transient visual obscurations.
Physical examination typically reveals bilateral papilledema and abducens nerve (CN VI) palsy due to increased intracranial pressure.
The diagnosis requires an MRI/MRV of the brain to rule out venous sinus thrombosis or space-occupying lesions.
Lumbar puncture is the diagnostic gold standard, demonstrating an elevated opening pressure (>25 cm H2O) with normal CSF composition.
First-line medical therapy is acetazolamide, a carbonic anhydrase inhibitor that decreases CSF production.
Untreated disease carries a high risk of permanent vision loss due to optic nerve atrophy.
Weight loss is the most important lifestyle modification to achieve long-term remission and prevent recurrence.
Vignette unlocked
A 26-year-old woman with a BMI of 34 kg/m² presents to the clinic complaining of a daily, throbbing headache that worsens with Valsalva maneuvers. She reports episodes of 'graying out' of her vision lasting several seconds when she stands up quickly. On physical exam, she has a CN VI palsy and bilateral optic disc swelling. An MRI of the brain is unremarkable, showing no mass effect or venous sinus thrombosis.
What is the most appropriate next step in the management of this patient?
Lumbar puncture to measure opening pressure
The patient presents with classic signs of IIH; after ruling out secondary causes via MRI, a lumbar puncture is required to confirm the diagnosis by documenting elevated opening pressure.
Full handout
High yield triage
Etiology / Epidemiology
Occurs primarily in obese women of childbearing age. Associated with tetracyclines, vitamin A, and oral contraceptives.
Clinical Manifestations
Presents with headache and papilledema. Classic finding is transient visual obscurations and CN VI palsy.
Diagnosis
Requires lumbar puncture showing opening pressure >25 cm H2O with normal CSF composition.
Treatment
Acetazolamide is first-line. Avoid in sulfa allergy. Surgical optic nerve sheath fenestration for vision loss.
Prognosis
Risk of permanent vision loss if untreated. Requires serial visual field testing.
Full handout
Epidemiology & Etiology
Predominantly affects obese women aged 20–45. Often linked to pseudotumor cerebri syndrome. Common triggers include tetracyclines, isotretinoin, growth hormone, and danazol.
Pertinent Anatomy
Increased intracranial pressure compresses the optic nerve sheath, leading to bilateral papilledema. The abducens nerve (CN VI) has a long intracranial course, making it highly susceptible to compression.
Pathophysiology
Impaired CSF absorption at the arachnoid villi leads to elevated intracranial pressure. This creates a state of pseudotumor where mass lesions are absent. Chronic pressure causes optic disc edema and potential axonal degeneration.
Clinical Manifestations
Patients report pulsatile tinnitus and daily headache that worsens with Valsalva. Physical exam reveals bilateral papilledema and CN VI palsy causing horizontal diplopia. Red flag: progressive vision loss or visual field constriction.
Diagnosis
Diagnosis of exclusion via MRI/MRV to rule out venous sinus thrombosis or mass. Lumbar puncture is the gold standard; diagnostic threshold is opening pressure >25 cm H2O in adults. CSF analysis must be normal.
Treatment
Weight loss is the only disease-modifying intervention. Acetazolamide is the first-line pharmacotherapy to decrease CSF production. Contraindicated in severe sulfa allergy. Refractory cases require optic nerve sheath fenestration or lumboperitoneal shunting.
Prognosis
Primary concern is permanent blindness due to optic atrophy. Patients require frequent visual field testing and funduscopic exams to monitor for progression.
Differential Diagnosis
Cerebral Venous Sinus Thrombosis: diagnosed via MRV
Brain Tumor: mass effect seen on MRI
Meningitis: abnormal CSF protein/glucose/cell count
Hydrocephalus: ventriculomegaly on imaging
Glaucoma: elevated intraocular pressure, not intracranial